B Hertenstein|A Ganser - JoVE Visualize

Showing results (1-10 of 369) with videos related to

Pageof 37

Sort By:

Der Internist|October 27, 2004

[Bone marrow transplantation. Indications, chances and perspectives]B Hertenstein, A Ganser

Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007

A comparative review of methods for T cell depletion in the prophylaxis of graft-versus-host diseaseB Hertenstein, L Arseniev, J Novotny, et al.

Journal of Hematotherapy & Stem Cell Research|May 3, 2000

Comparative evaluation of commonly used clones and fluorochrome conjugates of monoclonal antibodies for CD34 antigen detectionL Arseniev, N Pickerd, L Goudeva, et al.

Bone Marrow Transplantation|June 25, 2002

Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantationL Hambach, M Stadler, E Dammann, et al.

Annals of Hematology|December 3, 2003

Presentation assessment of minor histocompatibility antigens by predictive proteasomal cleavage analysisB Khattab, B Eiz-Vesper, A Ganser, et al.

Leukemia|September 14, 1999

Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantationM Eder, K Battmer, S Kafert, et al.

Annals of Hematology|March 31, 2000

Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberrationP Schöffski, A Ganser, U Pascheberg, et al.

Annals of Hematology|January 1, 1997

Acute abdomen due to endometriosis as a diagnostic and therapeutic challenge in the treatment of acute myelocytic leukemiaM Karthaus, A Prahst, R G Geissler, et al.

British Journal of Haematology|April 8, 1998

Sustained decrease of peripheral lymphocytes after allogeneic blood stem cell apheresesJ Novotny, J Kadar, B Hertenstein, et al.

Bone Marrow Transplantation|November 13, 2001

Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemiaL Hambach, M Eder, E Dammann, et al.

Pageof 37

Showing results (1-10 of 369) with videos related to

Sort By:

Pageof 37

Der Internist|October 27, 2004

[Bone marrow transplantation. Indications, chances and perspectives]B Hertenstein, A Ganser

Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007

A comparative review of methods for T cell depletion in the prophylaxis of graft-versus-host diseaseB Hertenstein, L Arseniev, J Novotny, et al.

Journal of Hematotherapy & Stem Cell Research|May 3, 2000

Comparative evaluation of commonly used clones and fluorochrome conjugates of monoclonal antibodies for CD34 antigen detectionL Arseniev, N Pickerd, L Goudeva, et al.

Bone Marrow Transplantation|June 25, 2002

Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantationL Hambach, M Stadler, E Dammann, et al.

Annals of Hematology|December 3, 2003

Presentation assessment of minor histocompatibility antigens by predictive proteasomal cleavage analysisB Khattab, B Eiz-Vesper, A Ganser, et al.

Leukemia|September 14, 1999

Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantationM Eder, K Battmer, S Kafert, et al.

Annals of Hematology|March 31, 2000

Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberrationP Schöffski, A Ganser, U Pascheberg, et al.

Annals of Hematology|January 1, 1997

Acute abdomen due to endometriosis as a diagnostic and therapeutic challenge in the treatment of acute myelocytic leukemiaM Karthaus, A Prahst, R G Geissler, et al.

British Journal of Haematology|April 8, 1998

Sustained decrease of peripheral lymphocytes after allogeneic blood stem cell apheresesJ Novotny, J Kadar, B Hertenstein, et al.

Bone Marrow Transplantation|November 13, 2001

Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemiaL Hambach, M Eder, E Dammann, et al.

Pageof 37